Shuttle Pharmaceuticals

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company that leverages its proprietary technology to develop novel therapies aimed at curing cancer. The company’s goal is to expand the benefits of cancer treatment by gaining a deep understanding of all aspects of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. Although several therapies aimed at curing cancer are under development, one of the most effective and proven methods is radiation therapy (RT). The company has developed technologies that operate in three distinct areas related to the use of radiation therapy in cancer treatment: sensitizing growing cancer cells to make them more susceptible to radiation therapy; and sensitizing hypoxic cells in radioresistant tumors.